Form 4 for BMY Bristol Myers Squibb
Accepted 2026-08-04 16:10:21 ET · period of report 2026-08-01 · accession 0002080176-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-04 16:10 | 2026-08-01 | BMY | Massacesi Cristian | EVP, Chief Med Offr, Head of Dev | M - OptEx | $0.00 | +51.2K | 51.2K | New | $0 |
| D | 2026-08-04 16:10 | 2026-08-01 | BMY | Massacesi Cristian | EVP, Chief Med Offr, Head of Dev | F - Tax | $65.31 | -26.2K | 25.0K | -51% | -$1.71M |
| D | 2026-08-04 16:10 | 2026-08-01 | BMY | Massacesi Cristian | EVP, Chief Med Offr, Head of Dev | M - OptEx | $0.00 | -51.2K | 153.5K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.10 par value | 2026-08-01 | M | A | 51,172 | $0.00 | 51,172 | D | — | — | (F1) The restricted share units will vest in four equal annual installments on the first, second, third, and fourth anniversaries of the grant date. |
| 2 | Common | Common Stock, $0.10 par value | 2026-08-01 | F | D | 26,175 | $65.31 | 24,997 | D | — | — | (F2) Shares withheld for payment of taxes upon vesting of awards. |
| 3 | Derivative | Restricted Stock Units | 2026-08-01 | M | D | 51,172 | $0.00 | 153,519 | D | — · — to 2029-08-01 | 51,172 Common Stock, $0.10 par value | (F3) Each restricted stock unit converts into one share of common stock upon vesting. (F1) The restricted share units will vest in four equal annual installments on the first, second, third, and fourth anniversaries of the grant date. |